RxDoctor Payments Data

Irina Bernescu, MD

Colon & Rectal Surgery · Baltimore, MDNPI 1174850952

Payments from drug & device makers

What this record shows

This record is dominated by education: $71,750 of the $92,634 with a category attached, or 77.5%. Intuitive Surgical accounts for 96.7% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2022 at $25,434 and has fallen 59.1% since, to $10,410 in 2025. Among colon & rectal surgery clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$92,634in general payments, 2019–2025

Across 155 payments — averaging $597.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$90K
  • Applied Medical Resources Corporation$744
  • Johnson & Johnson$601
  • Axonics, Inc.$326
  • Davol Inc.$293
  • Stryker$256
  • plus $827 from 13 others

What the payments were for

  • Speaking & faculty fees$5001%
  • Travel & lodging$11,86513%
  • Food & beverage$8,5199%
  • Education$71,75077%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$92,634 in reported general payments places this provider in the 95th percentile of 29 colon & rectal surgery providers in Maryland.

See all colon & rectal surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$86,879
Medicare patients
119
Services billed
353

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metronidazole20$90
Neomycin Sulfate14$72

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →